Association of Metabolic Syndrome with the Risk of Head and Neck Cancer: A 10-Year Follow-Up Study of 10 Million Initially Healthy Individuals
- PMID: 37627146
- PMCID: PMC10452383
- DOI: 10.3390/cancers15164118
Association of Metabolic Syndrome with the Risk of Head and Neck Cancer: A 10-Year Follow-Up Study of 10 Million Initially Healthy Individuals
Abstract
The aim of this national population-based retrospective study was to analyze the relationship between MetS and the incidence of HNC. In this Korean population-based cohort study, 9,598,085 subjects above the age of 20 were monitored from 1 January 2009 to 31 December 2018. In the study population, a total of 10,732 individuals were newly diagnosed with HNC during the 10-year follow-up. The hazard ratio (HR), after adjusting for age, gender, smoking status, alcohol intake, and exercise, indicated that participants with MetS were at a 1.06-fold (95% CI: 1.01-1.10) higher risk of having HNC than those without MetS. Participants with MetS showed an increased risk of developing oral cavity cancer (HR, 1.12; 95% CI, 1.03-1.23) and laryngeal cancer (HR, 1.18; 95% CI, 1.09-1.27). Among the components of MetS, elevated fasting glucose (HR = 1.04, 95% CI: 1.00-1.08) and elevated blood pressure (HR = 1.08, 95% CI: 1.04-1.13) were significantly associated with an increased HR for HNC in an adjusted multivariable model. The association between HNC and MetS remained significant even among individuals who had never smoked or were ex-smokers (HR: 1.09; 95% CI: 1.04-1.15), as well as those who did not drink or were mild drinkers (HR: 1.07; 95% CI: 1.02-1.12). The findings of this cohort study suggest MetS was associated with an increased risk for some types of HNCs. The results of this study could assist with etiological investigations and prevention strategies.
Keywords: Republic of Korea; epidemiology; head and neck neoplasms; metabolic syndrome; smoking.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Associations of Body Mass Index and Waist Circumference with the Risk of Head and Neck Cancer: A National Population-Based Study.Cancers (Basel). 2022 Aug 11;14(16):3880. doi: 10.3390/cancers14163880. Cancers (Basel). 2022. PMID: 36010881 Free PMC article.
-
Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study.Sci Rep. 2019 Jan 24;9(1):667. doi: 10.1038/s41598-018-37061-0. Sci Rep. 2019. PMID: 30679643 Free PMC article.
-
Association between γ-Glutamyltransferase and Head and Neck Cancer in Korean Population: A National Population-Based Study.Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1975-1982. doi: 10.1158/1055-9965.EPI-22-0401. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35944063
-
Association of Estimated Glomerular Filtration Rate with Risk of Head and Neck Cancer: A Nationwide Population-Based Study.Cancers (Basel). 2022 Oct 11;14(20):4976. doi: 10.3390/cancers14204976. Cancers (Basel). 2022. PMID: 36291759 Free PMC article.
-
Association of smoking status, duration and amount with the risk of head and neck cancer subtypes: a national population-based study.Am J Cancer Res. 2022 Oct 15;12(10):4815-4824. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381316 Free PMC article.
Cited by
-
Therapeutic Potential of Anti-Diabetes Drugs and Anti-Dyslipidemia Drugs to Mitigate Head and Neck Cancer Risk in Metabolic Syndrome.CNS Neurosci Ther. 2025 May;31(5):e70446. doi: 10.1111/cns.70446. CNS Neurosci Ther. 2025. PMID: 40387523 Free PMC article. Review.
-
A review on diabetes and oral cancer: Molecular links and implications.Mol Biol Res Commun. 2025;14(2):109-113. doi: 10.22099/mbrc.2024.51225.2042. Mol Biol Res Commun. 2025. PMID: 40028480 Free PMC article. Review.
References
-
- Hashibe M., Brennan P., Benhamou S., Castellsague X., Chen C., Curado M.P., Dal Maso L., Daudt A.W., Fabianova E., Fernandez L., et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J. Natl. Cancer Inst. 2007;16:777–789. doi: 10.1093/jnci/djk179. - DOI - PubMed
LinkOut - more resources
Full Text Sources